Leading Healthcare Company Signs Comprehensive Service Agreement with Dendrite.

BEDMINSTER, N.J. -- Large Sales Organization Selects Dendrite's Latest Help Desk and Hardware Service Solution

Dendrite International, Inc. (NASDAQ: DRTE) a leading provider of marketing, sales, and clinical services solutions for the pharmaceutical industry, today announced that a broad-based life sciences company, signed a renewal for a multi-year services contract with Dendrite. This engagement was referenced in the fourth quarter earnings release earlier this month.

Under the agreement, the Company will consolidate their current support services with Dendrite's help desk and hardware and asset management services, which are components of its First Source Sales Support(TM) solution. First Source(TM) is a best-in-class integrated set of services that support successful customer relationship management (CRM) and sales force automation (SFA) activities.

The Company selected Dendrite's First Source Sales Support services, based on a proven track record and the ability to deliver a quality solution. In this solution, Dendrite provides a single point of contact for all technology and business process concerns that routinely impact mobile pharmaceutical sales professionals. Dendrite integrates the company's technical and process support teams to provide a seamless solution to the mobile professionals. This solution delivers consolidation of issue tracking and reporting to ensure timely resolution and accurate documentation.

Dendrite's Sales support solutions are being utilized across the deployed mobile technology platforms, including laptops; tablet PCs, and handheld PDAs. The service is tailored to maximize uptime while efficiently managing all assets from purchase through the useful life and finally liquidation.

"Dendrite is committed to delivering world-class help desk support and hardware services to each and every client. Our focus is on improving the productivity of our customers, to help them grow their business and deliver value," said Natasha Giordano, Senior Vice President at Dendrite. "The continued growth of this pharmaceutical company over the past few years is indicative of a strong management team, committed staff and quality products. Its expansive network of sales representatives will benefit from our support organization that will strive to meet and exceed their expectations."

About Dendrite

Dendrite develops and delivers solutions that increase the productivity of sales, marketing, and clinical processes for pharmaceutical and other life science clients. Dendrite optimizes pharmaceutical product performance through a global solution framework of time-honored, custom-tailored technology, market insight and thought leadership. For more information, visit www.dendrite.com.

Note: Dendrite is a registered trademark of Dendrite International, Inc.

This document may contain forward-looking statements that may be identified by such forward-looking terminology as "expect," "believe," "anticipate," "will," "intend," "plan," "target," "outlook," "guidance," and similar statements or variations. Such forward-looking statements are based on our current expectations, estimates, assumptions and projections and involve significant risks and uncertainties, including risks which may result from our dependence on the pharmaceutical industry; fluctuations in quarterly revenues due to lengthy sales and implementation cycles for certain of our solutions; our fixed expenses in relation to fluctuating revenues and variations in customers' budget cycles; dependence on certain major customers; changes in demand for our products and services attributable to any weakness experienced in the economy or mergers, acquisitions and consolidations in the pharmaceutical industry; successful and timely development and introduction of new products and versions; rapid technological changes; increased competition; international operations; integrating the entities we acquire; our ability to effectively manage our growth; the protection of our proprietary technology; our ability to compete in the Internet-related products and services market; the continued demand for Internet-related products and services; the ability of our third party vendors to respond to technological change; our ability to maintain our relationships with third-party vendors; less favorable than anticipated results from strategic relationships; dependence of data solutions on strategic relationships; events which may affect the U.S. and world economies; and catastrophic events which could negatively affect our information technology infrastructure. Other important factors that should be reviewed and carefully considered are included in the company's 10-K, 10-Qs, and other reports filed with the SEC. Actual results may differ materially. The company assumes no obligation for updating any such forward-looking statements to reflect actual results, changes in assumptions or other changes affecting such forward-looking statements.